# Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.

> **NCT00307307** · PHASE4 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 69 (—)

## Conditions studied

- Established Carotid Atherosclerosis

## Interventions

- **DRUG:** Niacin/simvastatin compared to simvastatin alone at 2 doses

## Key facts

- **NCT ID:** NCT00307307
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 69 (—)
- **Last updated:** 2006-05-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307307, "Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00307307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*